The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Mitchell Krucoff
Showing 1-9 of 9 articles
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study
Sardella G,
Beerkens F,
Dangas G,
Cao D,
Baber U,
Sartori S,
Cohen D,
Briguori C,
Gil R,
Nicolas J,
Zhang Z,
Dudek D,
Kunadian V,
Kornowski R,
Weisz G,
Claessen B,
Marx S,
Escaned J,
Huber K,
Collier T,
Moliterno D,
Ohman EM,
Krucoff M,
Kastrati A,
Steg P,
Angiolillo D,
Mehta S,
Shlofmitz R,
Sharma S,
Pocock S,
Gibson C,
Mehran R
December 2, 2022 | 10.4244/EIJ-D-22-00319
ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike
Krucoff M,
Cao D,
Mehran R
August 19, 2022 | 10.4244/EIJ-E-22-00024
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M,
Louvard Y,
Lefèvre T,
Stankovic G,
Burzotta F,
Kassab G,
Lassen J,
Darremont O,
Garg S,
Koo B,
Holm N,
Johnson T,
Pan M,
Chatzizisis Y,
Banning A,
Chieffo A,
Dudek D,
Hildick-Smith D,
Garot J,
Henry T,
Dangas G,
Stone G,
Krucoff M,
Cutlip D,
Mehran R,
Wijns W,
Sharif F,
Serruys P,
Onuma Y
May 18, 2022 | 10.4244/EIJ-E-22-00018
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
Dangas G,
Baber U,
Sharma S,
Giustino G,
Sartori S,
Nicolas J,
Goel R,
Mehta S,
Cohen D,
Angiolillo D,
Zhang Z,
Camaj A,
Cao D,
Briguori C,
Dudek D,
Escaned J,
Huber K,
Collier T,
Kornowski R,
Kunadian V,
Moliterno D,
Ohman EM,
Weisz G,
Gil R,
Krucoff M,
Kaul U,
Oldroyd K,
Sardella G,
Shlofmitz R,
Witzenbichler B,
Kastrati A,
Han Y,
Steg PG,
Pocock S,
Gibson CM,
Mehran R
March 18, 2022 | 10.4244/EIJ-D-21-00721
Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients
Marquis-Gravel G,
Urban P,
Copt S,
Capodanno D,
Pocock S,
Sadozai Slama S,
Stoll H,
Tanguay J,
Mehran R,
Leon M,
Rao S,
Morice M,
Krucoff M
June 25, 2021 | 10.4244/EIJ-D-20-00749
Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology
Chang C,
Kogame N,
Onuma Y,
Byrne R,
Capodanno D,
Windecker S,
Morel M,
Cutlip D,
Krucoff M,
Stone G,
Lansky A,
Mehran R,
Spitzer E,
Fraser A,
Baumbach A,
Serruys P
January 17, 2020 | 10.4244/EIJ-D-19-00552
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document
Kappetein A,
Head S,
Généreux P,
Piazza N,
Van Mieghem NM,
Blackstone E,
Brott T,
Cohen D,
Cutlip D,
Van Es G-A,
Hahn R,
Kirtane A,
Krucoff M,
Kodali S,
Mack M,
Mehran R,
Rodés-Cabau J,
Vranckx P,
Webb JG,
Windecker S,
Serruys P,
Leon M
November 20, 2012 | 10.4244/EIJV8I7A121
Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trial
Nikolsky E,
Stone G,
Lee E,
Lansky A,
Webb JG,
Cox D,
Brodie B,
Turco M,
Rutherford B,
Kalynych A,
Antoniucci D,
Krucoff M,
Gibbons R,
Fahy M,
Mehran R
September 30, 2009
Meeting report. ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007
Daemen J,
Simoons M,
Wijns W,
Bagust A,
Bos G,
Bowen J,
Braunwald E,
Camenzind E,
Chevalier B,
Di Mario C,
Fajadet J,
Gitt A,
Guagliumi G,
Hillege H,
James S,
Jüni P,
Kastrati A,
Kloth S,
Kristensen S,
Krucoff M,
Legrand V,
Pfisterer M,
Rothman M,
Serruys P,
Silber S,
Steg PG,
Tariah I,
Wallentin L,
Windecker S
January 20, 2009
1
Latest news
AHEAD OF PRINT
Physiological changes post-CTO PCI and predictors
FREE ARTICLE - Sarosh A Khan et al
February 1, 2023
AHEAD OF PRINT
In-stent neoatherosclerosis in LEAD
FREE ARTICLE - Arne Müller et al
January 30, 2023
NEW ISSUE
M-TEER State-of-the-Art; Comparing ACURATE Neo2 to Evolut PRO/PRO + and the SAPIEN 3 Ultra; Mini Focus on Vulnerable Plaque: Plaque Composition and Vulnerability – Radial Wall Strain...
January 23, 2023
AHEAD OF PRINT
Cerebral embolic protection in TAVI
FREE ARTICLE - Rajesh K. Kharbanda et al
January 26, 2023
AHEAD OF PRINT
First experience of LAAO using a 3D mini TOE probe with conscious sedation
FREE ARTICLE - Laura Sanchis et al
January 25, 2023
AHEAD OF PRINT
“Lotus root”: a novel OCT imaging pattern in spontaneous coronary artery dissection
FREE ARTICLE - David del Val et al
January 20, 2023
AHEAD OF PRINT
Antiplatelet therapy following PCI for stable CAD
FREE ARTICLE - Anoop N. Koshy et al
January 19, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke